Patents for A61P 33 - Antiparasitic agents (21,787)
08/1997
08/26/1997US5661015 Recombinant coccidiosis vaccines
08/21/1997WO1997030159A2 Recombinant protein containing a c-terminal fragment of plasmodium msp-1
08/21/1997WO1997030158A2 Recombinant protein containing a c-terminal fragment of plasmodium msp-1
08/21/1997WO1997030072A1 Peptidomimetic inhibitors of cathepsin d and plasmepsins i and ii
08/21/1997WO1997029772A1 Recombinant canine herpesviruses
08/21/1997WO1997029766A1 Parasitic helminth larval thiol specific antioxidant proteins, nucleic acid molecules, and uses thereof
08/21/1997CA2245727A1 Recombinant protein containing a c-terminal fragment of plasmodium msp-1
08/21/1997CA2243662A1 Recombinant canine herpesviruses
08/21/1997CA2243562A1 Parasitic helminth larval thiol specific antioxidant proteins, nucleic acid molecules, and uses thereof
08/21/1997CA2241802A1 Recombinant protein containing a c-terminal fragment of plasmodium msp-1
08/20/1997EP0789593A1 Yeast-based delivery vehicles
08/20/1997EP0789586A1 Compounds for the prevention and treatment of helminth infections
08/20/1997EP0752813A4 Inhibitors of metazoan parasite proteases
08/20/1997CN1157564A Method of treating opportunistic infections with azaspiranes
08/20/1997CN1157145A Drug and its prescription for curing toxocariasis
08/19/1997US5658949 Inhibition of tumor necrosis factor by retinoic acid
08/19/1997CA1339309C Antiparasitic agents
08/14/1997WO1997029131A1 HUMAN ANTIBODIES THAT BIND HUMAN TNF$g(a)
08/13/1997EP0788366A1 Use of 2'-substituted oligonucleotides to down-regulating gene expression
08/12/1997US5656748 Selective hydrogenation of avermectins using rhodium-phosphine complex catalyst
08/12/1997US5656464 Lactic-acid-containing cyclic depsipeptides having 18 ring atoms as endoparasiticidal agents, and process for their preparation
08/12/1997US5656273 Administering; treats infection caused by helminth, schistosoma, and metazoan
08/06/1997EP0787141A2 Cyclic depsipeptide sulfonylation, sulfenylation and phosphorylation process
08/06/1997EP0787014A1 Use of flea proteases and protease inhibitors to protect animals from flea infestation
08/05/1997US5654446 Process for the preparation of dihydroartemisinin hemisuccinate
08/05/1997US5654304 Chemosensitizing agents; cancer therapy; drug resistance
07/1997
07/31/1997WO1997027300A1 TOXOPLASMA GONDII ANTIGEN Tg20
07/31/1997WO1997027202A1 Terpyridine-platinum(ii) complexes
07/31/1997WO1997026911A1 Malaria vaccine based upon the addition of a msa1 peptide
07/31/1997CA2242200A1 Toxoplasma gondii antigen tg20
07/31/1997CA2241992A1 Terpyridine-platinum(ii) complexes
07/30/1997EP0785924A1 Bis-2-aminopyridines, preparation method therefor and use thereof for controlling parasitic infections
07/29/1997US5652355 Hybrid oligonucleotide phosphorothioates
07/29/1997US5652213 Cyclic peptide antifungal agents
07/24/1997WO1997026006A1 Compositions and methods for administering borrelia burgdorferi antigens
07/24/1997WO1997007198A3 Dna sequences and secreted proteins encoded thereby
07/22/1997US5650405 Treatment for toxoplasmosis with a composition comprising a sulfonamide and a spiropiperidyl derivative of rifamycin S.
07/22/1997US5650397 Polyether antibiotic with nitro-p-diaminobenzene and benzimidazole
07/17/1997WO1997025046A1 Novel substituted imidazole compounds
07/15/1997US5648345 Treatment for toxoplasmosis with a composition comprising a macrolide antibiotic and a spiropiperidyl derivative of rifamycin S
07/10/1997WO1997024138A2 Medical use of proteases
07/10/1997WO1997024117A1 Substituted (aryl, heteroaryl, arylmethyl or heteroarylmethyl) hydroxamic acid compounds
07/09/1997CN1035356C Method for preparing antiparasitic formulations
07/08/1997US5646150 Methods of using lavendamycin analogs
07/08/1997US5646114 Anti-protozoan methods
07/02/1997EP0781846A2 Treponema pallidum fused antigen and assay for anti-treponema pallidum antibodies using the same fused antigen
07/02/1997EP0781338A1 VACCINES CONTAINING BORRELIA BURGDORFERI OspG
07/02/1997EP0781332A2 Enhancement of oligonucleotide inhibition of protein production, cell proliferation, and/or multiplication of infectious disease pathogens
07/02/1997EP0781141A1 Aza cyclohexapeptide compounds
07/02/1997CN1153513A N,N'-bis (quinolin-4-yl)-diamine derivs, their preparation and their use as antimalarials
07/02/1997CN1153176A Stable crystalline tetrahydrofolic acid salts
07/01/1997US5643909 10,11-Methanodibenzosuberane derivatives
07/01/1997US5643886 Avermectins and milbemycins to treat parasitic infestations in dogs
07/01/1997US5643578 Subunit vaccines
06/1997
06/25/1997EP0779817A1 Enteral vaccine for vaginal infections
06/24/1997US5641769 treatment for toxoplasmoisis with a composition containing a hydroxynaphthoquinone and a spiropiperidyl derivative of rifamycin S.
06/18/1997EP0779291A1 Heterocyclylcarbonyl substituted benzofuranyl-ureas
06/17/1997US5639876 Encoding protein capable of selectively binding to immune serum which inhibits helminth development
06/17/1997US5639873 Oligothionucleotides
06/17/1997US5639761 Antimalarial naphthylisoquinoline alkaloids and pharmaceutical compositions and medical uses thereof
06/12/1997WO1997020842A1 Novel purine derivatives having, in particular, antiproliferative properties, and biological uses thereof
06/12/1997WO1997020560A1 Use of 1-hydroxy-2-pyridones for treating mucosa diseases which are difficult to treat
06/12/1997WO1997020547A1 Endoparasiticidal agents
06/12/1997CA2192281A1 Heterocyclylcarbonyl substituted benzofuranyl-ureas
06/11/1997EP0778028A1 Compositions for the prevention and treatment of urogenital disorders, containing bismuth and one or more antimicrobials
06/11/1997EP0777733A1 Method of treating birds with avian myelomonocytic growth factor
06/11/1997EP0777683A1 Antiprotozoal cyclic tetrapeptides
06/11/1997EP0712411B1 Antiparasitic agents
06/11/1997CN1151287A Animal medicinal composition
06/10/1997US5637613 15-deoxyspergualin analogs, their method of preparation and their use in therapeutics
06/10/1997US5637603 Use of disulfonyl methanes and anthelmintics for the control of parasites
06/10/1997US5637577 Treatment of potozoal diseases
06/05/1997WO1997019692A1 Pharmaceutical compositions of macrolides or cyclosporine with a polyethoxylated saturated hydroxy-fatty acid
06/05/1997DE19545044A1 Endoparasitizide Mittel Endoparasiticides means
06/05/1997DE19544507A1 Cyclosporin enthaltende Präparate Cyclosporin-containing preparations
06/05/1997CA2238944A1 Pharmaceutical compositions of macrolides or cyclosporine with a polyethoxylated saturated hydroxy-fatty acid
06/04/1997EP0776665A1 Compositons for the prevention and treatment of urogenital disorders, containing bismuth
06/04/1997EP0630369B1 Benzimidazole anthelmintic agents
06/04/1997CN1151119A Medical use of bromelain
06/03/1997US5635499 Medicinal products and pure preparations of melarsomine dihydrochloride, process for obtaining them and intermediate products obtained
06/03/1997US5635490 Administering polyether antibiotic and benzimidazole derivative
05/1997
05/29/1997WO1997012582A3 Method for preventing and treating coccidiosis
05/28/1997EP0775746A2 Coccidiosis poultry vaccine
05/28/1997EP0774958A1 Vesicle formulation
05/22/1997WO1997018475A1 Compounds and methods for the detection and prevention of t. cruzi infection
05/22/1997WO1997018229A1 Parasitic helminth macrophage migration inhibitory factor proteins, nucleic acid molecules, and uses thereof
05/22/1997WO1997018193A1 Antimalarial quinolin derivatives
05/22/1997CA2237997A1 Antimalarial quinolin derivatives
05/22/1997CA2237818A1 Parasitic helminth macrophage migration inhibitory factor proteins, nucleic acid molecules, and uses thereof
05/21/1997CN1034930C Ornithine decarboxylase inhibiting branched aminooxy amino alkane derivatives and use thereof
05/21/1997CN1034929C Ornithine decarboxylase inhibiting cyclic aminooxy compounds and use thereof
05/20/1997US5631259 Cycloalkltriols containing cyclic substituents, processes and intermediate products for their preparation and their use as antiviral and antiparasitic agents
05/15/1997WO1997017084A1 Drug, in particular for modulating the immunological response for the control of viruses, tumours, bacteria and parasites
05/15/1997WO1997017073A1 A method of treating filariae
05/14/1997EP0773221A1 Stable crystalline tetrahydrofolic acid salts
05/14/1997EP0772677A1 T cell activation
05/14/1997EP0772619A1 Immunomodulatory oligonucleotides
05/14/1997EP0772445A1 Pharmaceutical compositions, mainly vaginal suppository, containing many different active ingredients
05/14/1997EP0686041B1 The use of anti-helminth vaccines in the control of parasite disease associated with loss of natural immunity
05/14/1997CN1149887A Compounds and methods for stimulation and enhancement of protective immune responses and IL-12 production